Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
24th Sep 20207:00 amRNSPre-Close Trading Update
21st Sep 20203:00 pmRNSNotice of Pre-Close Trading Statement
21st Sep 20202:30 pmRNSDirector/PDMR Shareholding
28th Aug 20203:00 pmRNSTotal Voting Rights
24th Aug 20203:00 pmRNSDirector/PDMR Shareholding
31st Jul 20203:00 pmRNSTotal Voting Rights
27th Jul 20203:15 pmRNSDirector/PDMR Shareholding
24th Jul 202010:00 amRNSHolding(s) in Company
2nd Jul 20207:00 amRNSHalf Year Results
30th Jun 20203:00 pmRNSTotal Voting Rights
29th Jun 20203:42 pmRNSDirector/PDMR Shareholding
29th Jun 20201:35 pmRNSNotice of Half Year Results
12th Jun 20207:00 amRNSCovid-19 Financing Update
1st Jun 20204:15 pmRNSDirector/PDMR Shareholding
29th May 20201:30 pmRNSTotal Voting Rights
18th May 20207:00 amRNSCOVID-19 Update
4th May 20203:00 pmRNSDirector/PDMR Shareholding
30th Apr 202011:16 amRNSTotal Voting Rights
14th Apr 20207:00 amRNSCOVID-19 Update
6th Apr 20203:30 pmRNSDirector/PDMR Shareholding
31st Mar 202012:30 pmRNSTotal Voting Rights
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSCoronavirus (COVID-19) Trading Update
9th Mar 20203:15 pmRNSDirector/PDMR Shareholding
28th Feb 202012:30 pmRNSTotal Voting Rights
10th Feb 20202:15 pmRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
22nd Jan 202011:15 amRNSResult of Annual General Meeting
13th Jan 20203:34 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSFirst Quarter Trading Update
7th Jan 20202:30 pmRNSNotice of first quarter trading update
2nd Jan 202011:00 amRNSTotal Voting Rights
16th Dec 20194:08 pmRNSDirector/PDMR Shareholding
16th Dec 201910:30 amRNSAnnual Report 2019
2nd Dec 20192:30 pmRNSDirector/PDMR Shareholding
2nd Dec 201911:00 amRNSDirector/PDMR Shareholding
29th Nov 20194:00 pmRNSDirector/PDMR Shareholding
29th Nov 20192:13 pmRNSTotal Voting Rights
28th Nov 20191:00 pmRNSDirector/PDMR Shareholding
27th Nov 20192:00 pmRNSDirector/PDMR Shareholding
27th Nov 201911:50 amRNSShort-Term Deferred Incentive Plan
26th Nov 201911:30 amRNSDirector/PDMR Shareholding
26th Nov 201911:30 amRNSDirector/PDMR Shareholding
25th Nov 201910:45 amRNSDirector/PDMR Shareholding
22nd Nov 20193:34 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSFull Year Results
18th Nov 20191:45 pmRNSDirector/PDMR Shareholding
11th Nov 20192:30 pmRNSNotice of Final Results
31st Oct 20192:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.